Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8168594rdf:typepubmed:Citationlld:pubmed
pubmed-article:8168594lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8168594lifeskim:mentionsumls-concept:C0023473lld:lifeskim
pubmed-article:8168594lifeskim:mentionsumls-concept:C0205341lld:lifeskim
pubmed-article:8168594lifeskim:mentionsumls-concept:C0032520lld:lifeskim
pubmed-article:8168594lifeskim:mentionsumls-concept:C1415900lld:lifeskim
pubmed-article:8168594lifeskim:mentionsumls-concept:C1552913lld:lifeskim
pubmed-article:8168594pubmed:issue3lld:pubmed
pubmed-article:8168594pubmed:dateCreated1994-6-2lld:pubmed
pubmed-article:8168594pubmed:abstractTextRepeated PCR analysis was performed on bone marrow and/or peripheral blood samples from 4 CML patients in complete cytogenetic remission during treatment with IFN-alpha. Two patients became PCR-negative. One was negative for the analyses carried out from the 9th to the 30th months, but reverted to PCR positivity 10 months after IFN was reduced from 1.5 x 10(6) IU/day to 1 x 10(6) IU and given on alternate days. Although the dose was again raised to 3 x 10(6) IU/day, 8 months later her peripheral blood cells were still PCR-positive, but remained persistently Ph'-negative. Another patient became PCR-negative at the 42nd month and remained so at the last analysis performed 3 months later. Two patients were persistently PCR-positive. Cytogenetic relapse was documented in both, in one while still on full therapy. Ph'-positive metaphases reappeared in the other patient 7 months after discontinuing IFN-alpha therapy.lld:pubmed
pubmed-article:8168594pubmed:languageenglld:pubmed
pubmed-article:8168594pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8168594pubmed:citationSubsetIMlld:pubmed
pubmed-article:8168594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8168594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8168594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8168594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8168594pubmed:statusMEDLINElld:pubmed
pubmed-article:8168594pubmed:monthMarlld:pubmed
pubmed-article:8168594pubmed:issn0902-4441lld:pubmed
pubmed-article:8168594pubmed:authorpubmed-author:RossoCClld:pubmed
pubmed-article:8168594pubmed:authorpubmed-author:SaglioGGlld:pubmed
pubmed-article:8168594pubmed:authorpubmed-author:DontiEElld:pubmed
pubmed-article:8168594pubmed:authorpubmed-author:FrauH PHPlld:pubmed
pubmed-article:8168594pubmed:authorpubmed-author:AddisMMlld:pubmed
pubmed-article:8168594pubmed:authorpubmed-author:LiberatiA MAMlld:pubmed
pubmed-article:8168594pubmed:authorpubmed-author:Lo CocoFFlld:pubmed
pubmed-article:8168594pubmed:authorpubmed-author:PardiniSSlld:pubmed
pubmed-article:8168594pubmed:authorpubmed-author:CoccoSSlld:pubmed
pubmed-article:8168594pubmed:issnTypePrintlld:pubmed
pubmed-article:8168594pubmed:volume52lld:pubmed
pubmed-article:8168594pubmed:geneSymbolABLlld:pubmed
pubmed-article:8168594pubmed:geneSymbolBCRlld:pubmed
pubmed-article:8168594pubmed:ownerNLMlld:pubmed
pubmed-article:8168594pubmed:authorsCompleteYlld:pubmed
pubmed-article:8168594pubmed:pagination152-5lld:pubmed
pubmed-article:8168594pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:meshHeadingpubmed-meshheading:8168594-...lld:pubmed
pubmed-article:8168594pubmed:year1994lld:pubmed
pubmed-article:8168594pubmed:articleTitleRepeated PCR in CML during IFN-alpha therapy.lld:pubmed
pubmed-article:8168594pubmed:affiliationInstitute of Internal Medicine and Oncology Science, University of Perugia, Italy.lld:pubmed
pubmed-article:8168594pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8168594pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed